4D Molecular Therapeutics, Inc. financial data

Symbol
FDMT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
5858 Horton Street #455, Emeryville, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.2K % +33.1%
Debt-to-equity 7.7 % -34.8%
Return On Equity -26.8 % +40.7%
Return On Assets -24.8 % +38.4%
Operating Margin -591 % +88.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49.8M shares +49.8%
Common Stock, Shares, Outstanding 51.2M shares +53.9%
Entity Public Float 630M USD +329%
Common Stock, Value, Issued 5K USD +66.7%
Weighted Average Number of Shares Outstanding, Basic 49.3M shares +50.6%
Weighted Average Number of Shares Outstanding, Diluted 49.3M shares +50.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 20.5M USD +826%
Revenue from Contract with Customer, Excluding Assessed Tax 20.5M USD +826%
General and Administrative Expense 38.8M USD +18.8%
Operating Income (Loss) -121M USD -6.29%
Nonoperating Income (Expense) 16.3M USD +318%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -105M USD +4.81%
Earnings Per Share, Basic -2.36 USD/shares +30.2%
Earnings Per Share, Diluted -2.36 USD/shares +30.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 276M USD +251%
Marketable Securities, Current 250M USD +105%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Assets, Current 536M USD +159%
Property, Plant and Equipment, Net 19.5M USD -9.95%
Operating Lease, Right-of-Use Asset 11.1M USD -12.5%
Other Assets, Noncurrent 771K USD -38.8%
Assets 630M USD +158%
Accounts Payable, Current 4.22M USD +75.1%
Employee-related Liabilities, Current 4.52M USD +29.7%
Accrued Liabilities, Current 9.01M USD +66.5%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 16.4M USD +45.4%
Contract with Customer, Liability, Noncurrent 1.32M USD +49.5%
Operating Lease, Liability, Noncurrent 11M USD -15.4%
Other Liabilities, Noncurrent 231K USD +697%
Liabilities 29.3M USD +15.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -109K USD +59.6%
Retained Earnings (Accumulated Deficit) -448M USD -30.5%
Stockholders' Equity Attributable to Parent 601M USD +175%
Liabilities and Equity 630M USD +158%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -29.1M USD -4.24%
Net Cash Provided by (Used in) Financing Activities 319M USD +2800%
Net Cash Provided by (Used in) Investing Activities -263M USD -710%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 51.2M shares +53.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 26.5M USD +1.02%
Deferred Tax Assets, Valuation Allowance 118M USD +44.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 123M USD +41.6%
Operating Lease, Liability 14.2M USD -9.64%
Depreciation 4.6M USD +53.3%
Payments to Acquire Property, Plant, and Equipment 710K USD -29.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -104M USD +3.95%
Lessee, Operating Lease, Liability, to be Paid 17.4M USD -13.3%
Property, Plant and Equipment, Gross 32.6M USD +7.24%
Operating Lease, Liability, Current 3.17M USD +18.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.14M USD -3.36%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.24M USD +3.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.26M USD -26.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.81M USD -10.4%
Deferred Tax Assets, Operating Loss Carryforwards 59.5M USD +26.6%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 11.9M USD +43.9%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.89M USD +2.99%
Operating Lease, Payments 3.1M USD +3.33%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 21.4M USD +23%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%